News

Articles

Ensysce Biosciences and Quotient Sciences are partnering to develop and test Ensysce’s novel opioid designed to prevent abuse and overdose.

Ensysce Biosciences and Quotient Sciences Announce Partnership 

EMA has recommended approval of Enjaymo for the treatment of hemolytic anemia in adult patients with cold agglutinin disease.

EMA Recommends Approval of Enjaymo

Emergence Therapeutics will work with Synaffix’s ADC technology platform to develop multiple ADCs against undisclosed targets.

Emergence Therapeutics to License Synaffix ADC Technology Platform in Deal Worth Up to $360 Million

MilliporeSigma’s €130 million (USD$132 million) investment is designed to increase manufacturing capacity of single-use assemblies.

MilliporeSigma to Invest €130 Million in French Manufacturing Facility

WHO has awarded prequalification to GSK’s Mosquirix, an approved malaria vaccine.

WHO Grants Prequalification to GSK’s Malaria Vaccine

Salipro has been granted patents in the United States and China for its proprietary technology to enable the development of therapeutics against challenging drug targets.

Salipro Biotech Obtains Patents in US and China for Direct Extraction of Membrane Proteins and Library Generation

Charles River Laboratories and Cure AP-4 will collaborate on gene therapy manufacturing for AP-4 hereditary spastic paraplegia.

Charles River and Cure AP-4 Announce Manufacturing Collaboration

In partnership with the University of Pittsburgh, ElevateBio will open its next manufacturing center in the city.

ElevateBio and the University of Pittsburgh Announce Creation of Pitt BioForge BioManufacturing Center

Roche’s acquisition of Good Therapeutics grants them rights to the company's conditionally activated PD-1-regulated IL-2 program.

Roche to Acquire Good Therapeutics for $250 Million

Lynparza has been approved in Great Britain as an adjuvant treatment for patients with germline BRCA-mutated HER2-negative high-risk early breast cancer.

Biopharma News